Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Axl/UFO (Extracellular region) Antibody | Login | Anti-Axl/UFO (Extracellular region) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-B7-H3/CD276 (Extracellular region) Antibody | Login | Anti-B7-H3/CD276 (Extracellular region) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Bad (Ser-26), Phosphospecific Antibody | Login | Anti-Bad (Ser-26), Phosphospecific Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Bad (Ser-112), Phosphospecific Antibody | Login | Anti-Bad (Ser-112), Phosphospecific Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-E-Cadherin (Cytoplasmic) Antibody | Login | Anti-E-Cadherin (Cytoplasmic) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-E-Cadherin (C-terminal fragment) Antibody | Login | Anti-E-Cadherin (C-terminal fragment) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-E-Cadherin (C-terminal region) Antibody | Login | Anti-E-Cadherin (C-terminal region) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-N-Cadherin (Cytoplasmic) Antibody | Login | Anti-N-Cadherin (Cytoplasmic) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-N-Cadherin (C-terminal region) Antibody | Login | Anti-N-Cadherin (C-terminal region) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-N-Cadherin (Tyr-820), Phosphospecific Antibody | Login | Anti-N-Cadherin (Tyr-820), Phosphospecific Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Unphosphorylated N-Cadherin (Tyr-820) Antibody | Login | Anti-Unphosphorylated N-Cadherin (Tyr-820) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-N-Cadherin (C-terminal region) Antibody | Login | Anti-N-Cadherin (C-terminal region) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-N-Cadherin (Y860) [E-Cadherin (Y835)], Phosphospecific Antibody | Login | Anti-N-Cadherin (Y860) [E-Cadherin (Y835)], Phosphospecific Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-VE-Cadherin (C-terminal) Antibody | Login | Anti-VE-Cadherin (C-terminal) Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-VE-Cadherin (Tyr-685), Phosphospecific Antibody | Login | Anti-VE-Cadherin (Tyr-685), Phosphospecific Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Peripherin Antibody | Login | Anti-Peripherin Antibody | ||||||||||||||||
|
||||||||||||||||||
| Anti-Peripherin Antibody | Login | Anti-Peripherin Antibody | ||||||||||||||||
|
||||||||||||||||||
| CSF3R Antibody (Center) Blocking Peptide | Login | CSF3R Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| NTRK2 Antibody (Center) Blocking Peptide | Login | NTRK2 Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| KIF11 Antibody (N-term) Blocking Peptide | Login | KIF11 Antibody (N-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| RPA2 Antibody (N-term) ) Blocking Peptide | Login | RPA2 Antibody (N-term) ) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| HOXA9 Antibody (C-term) Blocking Peptide | Login | HOXA9 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CD47 Antibody (C-term) Blocking Peptide | Login | CD47 Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| CIRBP Antibody (C-term) Blocking Peptide | Login | CIRBP Antibody (C-term) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
| MUTYH Antibody (Center) Blocking Peptide | Login | MUTYH Antibody (Center) Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||


